Kevin Stevenson, MD
Neurological Surgery · Macon, GANPI 1821042946
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (58.1%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Medacta USA, Inc. accounts for 84.7% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2024 at $30,887 and has fallen 91.7% since, to $2,565 in 2025.
Across 111 payments — averaging $556.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medacta USA, Inc.$52K
- Globus Medical$7K
- Boston Scientific$2K
- Degen Medical, Inc.$560
- Flowonix Medical Incorporated$74
- DJO, LLC$44
- plus $27 from 1 others
What the payments were for
- Royalty or licence$2,2634%
- Consulting fees$35,92158%
- Travel & lodging$20,14433%
- Food & beverage$3,4836%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medacta USA, Inc. | 45 | $52,341 |
| Globus Medical | 26 | $7,058 |
| Boston Scientific | 33 | $1,705 |
| Degen Medical, Inc. | 1 | $560 |
| Flowonix Medical Incorporated | 2 | $74 |
| DJO, LLC | 3 | $44 |
| Team 1, LLC | 1 | $27 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MYSPINE$39,487
- MUST$6,750
- RISE Intra LIF$4,890
- MUST MINI Set Screw$900
- RISE-L . RISE-L A/L$801
- RISE$560
- GENERAL PAIN MANAGEMENT$410
How this compares
$61,810 in reported general payments places this provider in the 80th percentile of 201 neurological surgery providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 100 | $2,197 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 94 | $1,989 |
| Methocarbamol | 170 | $1,656 |
| Gabapentin | 53 | $719 |
| Ciprofloxacin Hcl | 62 | $414 |
| Morphine Sulfate ErMorphine Sulfate | 40 | $272 |
| Tizanidine Hcl | 35 | $238 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 20 | $224 |
| Cyclobenzaprine Hcl | 25 | $191 |
| Tramadol Hcl | 18 | $156 |
| Methylprednisolone | 20 | $123 |
| Meloxicam | 29 | $95 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Macon
- Igor de CastroMacon$450K
- Regis HaidAtlanta$25.5M
- John CowanRome$3.2M
- Thomas MorrisonAtlanta$2.8M
- Christopher TomarasAtlanta$1.5M
- Daniel RefaiAtlanta$1.2M
- Gerald RodtsAtlanta$1.2M
- Betsy GrunchGainesville$1.1M
- James RobinsonAtlanta$993K
- Michele JohnsonAtlanta$540K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.